Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$181.44 - $260.22 $4.54 Million - $6.51 Million
25,000 New
25,000 $6.29 Million
Q4 2022

Feb 14, 2023

BUY
$151.88 - $228.5 $1.14 Million - $1.71 Million
7,500 New
7,500 $1.67 Million
Q2 2022

Aug 15, 2022

SELL
$116.09 - $227.33 $2.9 Million - $5.68 Million
-25,000 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$187.51 - $283.98 $4.69 Million - $7.1 Million
25,000 New
25,000 $5.55 Million
Q2 2020

Aug 14, 2020

SELL
$153.32 - $191.72 $8.19 Million - $10.2 Million
-53,400 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$124.34 - $193.76 $1.04 Million - $1.63 Million
8,400 Added 18.67%
53,400 $8.62 Million
Q4 2019

Feb 13, 2020

BUY
$134.81 - $177.8 $6.07 Million - $8 Million
45,000 New
45,000 $7.39 Million

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.37B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.